Milenkovikj, Tatjana
Preferred name
Milenkovikj, Tatjana
Official Name
Milenkovikj, Tatjana
Alternative Name
Татјана Миленковиќ
Milenkovikj Tatjana
Milenkovik Tatjana
Milenkovic Tatjana
Миленковиќ Татјана
Миленковиќ Т
T. Milenkovic
T Milenkovic
Milenkovic T
Milenkovic. T
Т Миленковиќ
Т. Миленковиќ
Milenkovic Tatjana
Tatjana Milenkovic
Main Affiliation
Email
tatjana.milenkovikj@medf.ukim.edu.mk
62 results
Now showing 1 - 10 of 62
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Case report on a switch from hypothyroidism to hyperthyroidism(The Endocrine Society, 2023-01-18) ;Todorova, Biljana; ; ;Stevcevska, AleksandraHashimoto's thyroiditis and Graves’ disease are the most common autoimmune thyroid conditions and are more common in women than in men. Thyrotropin receptor (TSHR) antibodies that stimulate the thyroid (TSAb) cause Graves’ hyperthyroidism and TSHR antibodies which block thyrotropin action (TBAb) are occasionally responsible for hypothyroidism. Unusual patients switch from TSAb to TBAb (or vice versa) with concomitant thyroid function changes.The most common scenario is the evolution from Graves’ disease (GD) to Hashimoto's thyroiditis (HT), whereas the switch from HT into GD seems to be less common. 53-year-old woman presented with a several month's history of tiredness, cold intolerance and hoarseness in October 2020. She was diagnosed with autoimmune hypothyroidism and achieved euthyroid status following treatment with Tbl. Levothyroxine a 50 mcg S. 1×1. This almost stable status was interestingly interrupted after 9 months (January 2021) when the patient on a regular checkup got laboratory results that showed suppressed TSH levels and a high fT4. The substitution therapy was discontinued immediately. The ultrasound of the thyroid gland showed nonspecific changes: hypoechoic, inhomogeneous gland without any markable pathological formations. The patient was feeling tired, she had palpitations, sweating that is not connected to a physical activity, shaking of the hands and uncontrolled movements of the extremities and neck. Her hair started to fall rapidly in the past few months. She was given Tbl. Metoprolol a 100 mg S.1×1 and Tbl ASA a 100 mg S. 1X1.In October 2021, the new laboratory results showed TSH <0.005 mU/l; fT4 =33.36, aTP-O= 22.77 iU/ml thyroglobulin =46,62, Calcitonin=2.99, Vit. D3=27.3, TSH receptor antibodies= 15.40. Antithyroid therapy was required, and she was given Tbl Thiamazole, Tbl. Propronalol because of the developed clinically and laboratory confirmed hyperthyroidism. There were oscillations in the thyroid status in the first months after the switch to hyperthyroidism, and in December 2021 there was a discontinuation of the Thiamazole treatment for one month because of the unstable TSH level, but afterwards from January 2022 the therapy is administered again and the patient is so far clinically stable under regular control. The patient is feeling good. Conclusion:This rare switch from a state of hypothyroidism to a state of hyperthyroidism is not very common in the clinical endocrinology practice, but should not be missed or misdiagnosed. Suspicion should be raised in the very first moment of tapering the levothyroxine doses in any patient with diagnosed HT during a regular follow up. Our recommendation is doing the TRABs (if available) at the moment of lowering the levothyroxine doses along with the regular laboratory tests of fT4, TSH, ATP-O. If there are any TRABs elevated, the leading way is to think and manage the possible and probable onset of hyperthyroidism - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine(Springer, 2014-12); ; ; ;I. Ahmeti - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Direct Molecular Diagnosis of CYP21A2 Point Mutations in Macedonian and Serbian Patients with 21-Hydroxylase Deficiency(Society of Medical Biochemists of Serbia, 2015-01); ; Steroid 21-hydroxylase deficiency is present in 90-95% of all cases with congenital adrenal hyperplasia (CAH), an autosomal recessive disorder. It can present as the severe classical salt wasting (SW) or simple virilising (SV) form, or the milder, nonclassical form. Nine pseudogene-derived point mutations account for about 80% of all defects in the CYP21A2 gene coding the 21-hydroxylase enzyme. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Obstructive Sleep Apnea and Lipid Abnormalities(ID-Design/Scientific foundation SPIROSKI, 2017-03-15); ;Georgievski, Oliver; ; There has been a great interest in the interaction between obstructive sleep apnea (OSA) and metabolic dysfunction, but there is no consistent data suggesting that OSA is a risk factor for dyslipidemia. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Prediabetes awareness among Southeastern European physicians(Wiley Online Library, 2017-08-29) ;Kokic, Visnja ;Kokic, Slaven ;Krnic, Mladen ;Petric, MarinLiberati, Ana MarijaPrediabetes (PD) represents a transitional state where the glucose levels are higher than normal, but not enough for diabetes mellitus diagnosis. As there is a growing number of the population with PD, its early detection and treatment could prevent the development of diabetes mellitus and its complications. We aimed to assess the overall knowledge of PD among medical professionals of different varieties. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Severe hyponatremia as presenting symptom of small cell lung carcinoma(The Endocrine Society, 2023-01) ;Stevchevska, Aleksandra; ;Todorova, Biljana; A 62-year-old female patient was admitted to ICU in our clinic with symptomatic severe hyponatremia with complaints of fatigue, vertigo, paresthesia of upper extremities and three episodes of loss of consciousness in the past month. She had been hospitalized two weeks before in neurology clinic because of the same symptoms. CT of the brain, EEG, ophthalmology examinations were negative. She did not complain of hemoptysis, cough, weight loss, fever, chest pain or dyspnea. Nephrologist was consulted and renal origin of the hyponatremia was excluded, before admission. Initial laboratory tests were glucose:5,47 umol/L,sodium:109 mEq/L,potassium;4.5 mEq/L,urea 3,9 umol/l;creatinine:52,7 mol/l,calcium:1,22umol/L,TSH 5;Cortisol 819nmol/L;ACTH:16,34 pg/ml. Her medical history included hypertension, primary hypothyroidism and history of smoking. Upon laboratory findings of low serum osmolality, high urine osmolality, high urine sodium levels and clinical euvolemia, and in the absence of renal, pituitary disfunction, adrenal insufficiency, inappropriate ADH syndrome was diagnosed and initially was treated with 3% NaCl. Since this treatment had no effect, it was started with fluid restriction, per os sodium intake was increased and therapy with loop diuretic was initiated, which resulted in correction of the hyponatremia. For the etiology consideration of inappropriate ADH syndrome CT of the thorax was performed, which revealed a neo infiltrative process with atelectasis in the poster basal segment of the left lobe. Histopathological sampling from the biopsy of the mass revealed small cell carcinoma of the lung. Metastasis were not detected. Since basal morning cortisol level was above upper range, with inappropriate measurements of ACTH constantly above 15 pg/ml, additional tests for ectopic Cushing syndrome were done. Overnight 1mg dexamethasone suppression test showed absent suppression of the morning cortisol values of 656nmol/L and ACTH of 22,14 pg/ml and absent circadian rhythm of cortisol secretion, with high measurements of midnight serum cortisol of 652 nmol/L. Diagnosis of ectopic Cushing syndrome and SIADH as part of paraneoplastic syndrome in small cell lung carcinoma was made. It is to be noted that patient had no significant symptoms or signs of hypercortisolemia.</jats:p> <jats:p>We report here a case of small cell carcinoma of the lung whose first presentation was with symptomatic hyponatremia as a result of inappropriate ADH syndrome. The most common neoplasms associated with hyponatremia are various forms of lung cancer. Because of the aggressive nature of the disease, the most common manifestation of small cell carcinoma of the lung is a metastatic one. Therefore, identifying the disease in earlier stages is very important. Unfortunately, these patients have low rates of survival and face a very poor prognosis even with treatment. The presence and early identification of paraneoplastic syndromes can be beneficial in this context. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The beneficial effect of L-thyroxine on lipid parameters in mild form of subclinical hypothyroidism(Bioscientifica, 2016-05-13) ;Nakova, Valentina Velkoska; ; ; Introduction: Overt hypothyroidism and severe subclinical hypothyroidism (ScH) are associated with dyslipidaemia, and its condition is reversible after thyroid replacement therapy. We investigated the effect of levothyroxine therapy on lipid parameters in patients with mild form of subclinical hypothyroidism (ScH). Material and methods: Fifty-seven patients with newly diagnosed ScH with TSH levels below 10 mU/l and 30 age and sex-matched healthy subjects were included in the study. Lipid parameters were evaluated at the first visit in both groups, and after 6 months euthyroid stage in patients with ScH. Results: Average value of TSH in patients with ScH was 8.1 mU/l. At the baseline, ScH patients has a significantly higher total cholesterol and LDL-C levels, and lower HDL-C, than the control group (5.6±0.9 vs. 4.8±1.1, 3.4±1.0 vs. 2.9±0.8, and 1.5±0.5 vs. 1.7±0.9, mmol/L, P<0.05, respectively). Thyroid substitution therapy in ScH group, significantly decreased total cholesterol and LDL-C, and increased HDL-C (5.6±0.9 vs. 5.3±1.1, 3.4±1.0 vs. 3.2±1.1, 1.5±0.5 vs. 1.6±0.5, mmol/L, P<0.05 respectively). Also, TSH positively correlated with total cholesterol (r=0.147, P<0.05). Conclusion: Mild form of ScH is associated with hipercholesterolemia, which is reversible after levothyroxine treatment. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Diabetes Care in Republic of Macedonia: Challenges and Opportunities(Ubiquity Press, 2015) ;Ivica Smokovski; ;Caroline TrappAleksandar MitovThe Republic of Macedonia (RoM) has experienced a rapid rise in the prevalence of type 2 diabetes (T2D) over the past 2 decades, a period characterized by significant social, political, and economic change. RoM now has one of the highest rates of diabetes in Europe. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association Between Hormone Replacement Therapy and Glycemic Control in Postmenopausal Women with Type 2 Diabetes(Македонско лекарско друштво = Macedonian medical association, 2015-01); ; ; ;Markovik-Temelkova, SnezhanaJovanovska-Misevska, SasaIntroduction. In women with diabetes, the changes that accompany menopause may further diminish glycemic control. Little is known about how hormone replacement therapy (HRT) affects glucose metabolism in diabetes. The aim of this study was to examine whether HbA1C levels are influenced by current HRT among postmenopausal women with type 2 diabetes. Methods. A total of 40 postmenopausal women with type 2 diabetes were enrolled. All of them fulfilled the criteria of natural menopause, with intact uterus, low estrogen levels (E2) and high follicle-stimulating hormone (FSH) levels. Half of them (20 women) were assigned to take HRT (DM-HRT group). The other half (20 women) were assigned to the control group, those who did not take HRT (DM-non HRT group). HRT consisted of 17 β-estradiol (E2) 1 mg and drospirenone (DRSP) 2 mg. Fasting plasma glycemia, insulinemia and HbA1C were followed in both groups throughout 12 months. Results. The mean age was 49 years (SD±3,3) and 48,5 (SD±3.1), respectively. HRT was associated with statistically significant decrease in serum fasting glucose, HbA1C and insulinemia levels in the DM-HRT group. There was no significant reduction in glucose levels and HbA1C together with no significant increase in insulinemia levels in the DM non-HRT group throughout 12 months. Conclusion. HRT was associated with statistically significant decrease of plasma glucose levels and HbA1C level. Larger clinical trials are necessary to understand whether HRT may improve glycemic control in women with diabetes, especially when it is given shortly after entering menopause.
